Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Explore linked clinical trials.18 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07767253 | |
| The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 2 | 2026-07-28 | NCT07507513 | |
| A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment | Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Not yet recruiting | Phase 2 | 2026-07-20 | NCT07708181 | |
| A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis | AD | Recruiting | Phase 1 | 2026-07-10 | NCT07693738 | |
| A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-01-29 | NCT06680947 | |
| A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) | Axial Spondyloarthritis, Non-Radiographic Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Not yet recruiting | Phase 3 | 2026-01-16 | NCT07349329 | |
| Efficacy and Safety Study of 610 in Patients With Severe Asthma | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 3 | 2026-01-07 | NCT06323213 | |
| A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) | Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Recruiting | Phase 3 | 2025-12-10 | NCT07261644 | |
| A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps | Infections, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, nasal cavity polyp, nasal disorder, otorhinolaryngologic disease, paranasal sinus disorder, polyp, respiratory system disorder, respiratory tract infectious disorder, sinusitis | Active, not recruiting | Phase 3 | 2025-12-03 | NCT06639295 | |
| The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 / Phase 2 | 2025-11-26 | NCT07185269 | |
| Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 3 | 2025-11-18 | NCT07042126 | |
| Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 3 | 2025-11-18 | NCT07039669 | |
| Evaluation of 627 in Healthy Adult Subjects | Healthy Subjects (HS) | Not yet recruiting | Phase 1 | 2025-07-15 | NCT07065136 | |
| A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 1 | 2025-06-27 | NCT07042113 | |
| A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) | Axial Spondyloarthritis, Non-Radiographic Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Recruiting | Phase 2 | 2025-03-11 | NCT06222671 | |
| A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 2 | 2024-10-21 | NCT06522828 | |
| A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm | Recruiting | Phase 1 | 2024-10-18 | NCT06390774 | |
| A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2024-09-19 | NCT06493760 |